Skip to content
Create startup

New Owner

Gilead Sciences - Nimbus Apollo

Gilead Sciences acquires Nimbus Apollo

Announced: April 04, 2016
Closed:        May 17, 2016

Type:           Acquisition
Status:         Complete

Amount:       Undisclosed amount

Acquisition News

Add News

Date Title
May 17, 2016 Business Wire - Nimbus Therapeutics Announces Closing of Gilead Sciences’ Acquisition of Nimbus Apollo, Inc., and its Acetyl-CoA Carboxylase (ACC) Inhibitor Program
Nimbus Therapeutics Announces Closing of Gilead Sciences’ Acquisition of Nimbus Apollo, Inc., and its Acetyl-CoA Carboxylase (ACC) Inhibitor Program
Oct 15, 2015 BioSpace - Bay Area Startup Lyra Health Closes 35 Million Series A Round Plans Launch of Employer Facing Mental Health Services Platform for Q1 2016
Bay Area Startup Lyra Health Closes 35 Million Series A Round Plans Launch of Employer Facing Mental Health Services Platform for Q1 2016

Gilead Sciences Other Acquisitions

Add Acquisition

Date Acquired Amount
Aug 28, 2017
Kite Pharma
Kite Pharma
 $ 11,900,000,000
May 06, 2015
Epitherapeutics
Epitherapeutics
 $ 65,000,000
Jan 06, 2015
Phenex Pharmaceuticals
Phenex Pharmaceuticals
 $ 470,000,000
Feb 08, 2013
YM BioSciences
YM BioSciences
 $ 487,600,000
Nov 21, 2011
Pharmasset
Pharmasset
 $ 11,000,000,000
View more acquisitions »